Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Split Septum
Showing 1–12 of 16 results
Infusion Therapy Market Size, Share & Trends Analysis | Global | 2024-2030 | MedSuite | Includes: Infusion Pumps, Intravenous Sets, and 4 more
Overall, the global infusion therapy market was valued at $11.7 billion in 2023, a 4.5% increase from $11.2 billion in 2022. This is expected to increase over the forecast period at a CAGR of 3.7% to reach $15.0 billion. Currently, the global infusion therapy market is dominated by Becton Dickinson (BD) and B. Braun. Throughout […]
more...Infusion Therapy Market Size, Share & COVID19 Impact Analysis | Europe | 2023-2029 | MedSuite | Includes: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks & Blood Transfusion Sets
In 2022, the European Infusion Therapy Device Market size was valued at $1.1 billion. By the end of the forecast period, the market size is expected to increase to reach a value of at least €1.3 billion by 2029. Throughout this medical market research, we analyzed 46 infusion therapy companies across Europe and used our […]
more...Infusion Therapy Market Size, Share & COVID19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks, Intravenous Filters & Blood Transfusion Devices
The Infusion Therapy Device Market in the United States had a valuation of $3.0 billion in 2022. With a projected compound annual growth rate (CAGR) of 2.5%, it is estimated to surpass $3.6 billion by the end of the forecast period. Throughout this medical market research, we analyzed over 40 Infusion Therapy companies across the […]
more...